ENZ(Delisted)
Enzo Biochem·NYSE
--
--(--)
Enzo Biochem (ENZ) Financial Statements
Enzo Biochem (ENZ) Cash Flow Statement
During Q1 2025, Enzo Biochem (ENZ) generated -8.99M in cash flow from operating activities, 4.55M from investing activities, and -200.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2014 | Q1,2015 | Q1,2016 | Q1,2017 | Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q1,2024 | Q1,2025 | TTM |
|---|
Start Date | Aug 1, 2013 | Aug 1, 2014 | Aug 1, 2015 | Aug 1, 2016 | Aug 1, 2017 | Aug 1, 2018 | Aug 1, 2019 | Aug 1, 2020 | Aug 1, 2021 | Aug 1, 2022 | Aug 1, 2023 | Aug 1, 2024 | -- |
End Date | Oct 31, 2013 | Oct 31, 2014 | Oct 31, 2015 | Oct 31, 2016 | Oct 31, 2017 | Oct 31, 2018 | Oct 31, 2019 | Oct 31, 2020 | Oct 31, 2021 | Oct 31, 2022 | Oct 31, 2023 | Oct 31, 2024 | -- |
Fiscal Year-End | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | Jul 31 | -- |
Net Cash Flows from Operating Activities | -3.31M -- | -2.75M +16.72% | 13.15M +577.42% | -333.00K -102.53% | 2.60M +879.28% | -6.20M -339.08% | -2.07M +66.70% | -1.21M +41.53% | -6.04M -400.25% | -8.69M -43.85% | -13.37M -53.85% | -8.99M +32.78% | -- -- |
Depreciation and Amortization | 1.02M -- | 938.00K -8.49% | -- -- | 927.00K -- | 749.00K -19.20% | 519.00K -30.71% | 579.00K +11.56% | 585.00K +1.04% | 611.00K +4.44% | 780.00K +27.66% | 270.00K -65.38% | 319.00K +18.15% | -- -- |
Change in Working Capital | -2.35M -- | -1.15M +51.17% | -- -- | -1.13M -- | 1.09M +196.47% | -1.72M -257.69% | 4.65M +369.92% | -2.70M -158.02% | -5.35M -98.22% | -271.00K +94.93% | -16.27M -5902.95% | -11.99M +26.28% | -- -- |
Net Cash Flows from Investing Activities | -314.00K -- | -259.00K +17.52% | -490.00K -89.19% | -514.00K -4.90% | -461.00K +10.31% | -1.01M -120.17% | -274.00K +73.00% | -617.00K -125.18% | -1.06M -71.96% | -652.00K +38.55% | -254.00K +61.04% | 4.55M +1892.13% | -- -- |
Purchase of PPE and Intangible Assets | 334.00K -- | 264.00K -20.96% | -- -- | 514.00K -- | 461.00K -10.31% | 406.00K -11.93% | 274.00K -32.51% | 617.00K +125.18% | 1.03M +67.42% | 652.00K -36.88% | 254.00K -61.04% | 448.00K +76.38% | -- -- |
Increase in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 28.00K -- | -- -- | -- -- | -- -- | -- -- |
Net Cash Flows from Financing Activities | 1.97M -- | 2.21M +12.09% | -125.00K -105.66% | 303.00K +342.40% | 557.00K +83.83% | -34.00K -106.10% | -171.00K -402.94% | -113.00K +33.92% | -57.00K +49.56% | -95.00K -66.67% | -518.00K -445.26% | -200.00K +61.39% | -- -- |
Change in Capital Stock | 1.68M -- | 2.32M +37.89% | -- -- | -- -- | -- -- | 25.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Increase in Capital Stock | 1.68M -- | 2.32M +37.89% | -- -- | -- -- | -- -- | 25.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Effect of Foreign Exchange Rate Changes | 72.00K -- | -57.00K -179.17% | -5.00K +91.23% | -19.00K -280.00% | -9.00K +52.63% | -11.00K -22.22% | 8.00K +172.73% | -13.00K -262.50% | -7.00K +46.15% | -28.00K -300.00% | -20.00K +28.57% | 2.00K +110.00% | -- -- |
Net Increase in Cash and Cash Equivalents | -1.58M -- | -864.00K +45.35% | 12.53M +1550.58% | -563.00K -104.49% | 2.68M +576.38% | -7.26M -370.84% | -2.50M +65.54% | -1.95M +22.05% | -7.17M -267.40% | -9.47M -32.09% | -14.17M -49.62% | -4.64M +67.27% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 9.01M -- | 17.45M +93.79% | 18.11M +3.75% | 67.78M +274.27% | 64.17M -5.33% | 60.04M -6.43% | 60.15M +0.17% | 48.62M -19.17% | 14.27M -70.64% | 22.60M +58.35% | 83.37M +268.86% | 52.37M -37.18% | -- -- |
Cash and Cash Equivalents at End of Period | 7.43M -- | 16.59M +123.42% | 30.64M +84.69% | 67.21M +119.35% | 66.85M -0.54% | 52.78M -21.05% | 57.64M +9.22% | 46.66M -19.05% | 7.11M -84.77% | 13.13M +84.84% | 69.21M +426.89% | 47.73M -31.03% | -- -- |
You can ask Aime
No Data
